Allero Therapeutics

Rotterdam, The Netherlands

Allero Therapeutics is a biopharmaceutical company.

$2.9M raised

Oct 2021

Grant

Biotechnology Pharmaceutical

Top Investors

European Innovation Council EISMEA Swanbridge Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Allero Therapeutics

How much funding has Allero Therapeutics raised?

Allero Therapeutics has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in October 2021.

Who are Allero Therapeutics's investors?

Allero Therapeutics's investors include European Innovation Council, EISMEA, Swanbridge Capital.

Where is Allero Therapeutics headquartered?

Allero Therapeutics is headquartered in Rotterdam, The Netherlands.

What does Allero Therapeutics do?

Allero Therapeutics is a biopharmaceutical company.

What stage is Allero Therapeutics at?

Allero Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 21, 2021.

MLA

"Allero Therapeutics — Funding & Investors." VCBacked, October 21, 2021, https://www.vcbacked.co/company/allero-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2021). Allero Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/allero-therapeutics

Wikipedia (cite web)

{{cite web |title=Allero Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/allero-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 21, 2021.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K